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RESEARCH REPORT

Method for discovering novel DNA viruses
in blood using viral particle selection and
shotgun sequencing
Mya Breitbart and Forest Rohwer
BioTechniques 39:729-736 (November 2005)
doi 10.2144/000112019

Rapid identification of viruses is needed to monitor the blood supply for emerging threats. Here we present a method that meets
these criteria and allows for the shotgun sequencing of novel, uncultured DNA viruses directly from human blood. This method
employs selection based on the physical properties of viruses combined with sequence-independent amplification and cloning. We
show that both single- and double-stranded DNA viruses can be recovered from blood samples using this approach. In addition, we
report the discovery of novel anellovirus sequences in the blood of healthy donors. PCR primers designed to amplify these novel
anellovirus sequences were then used to verify the presence of these viruses in the general donor population.

INTRODUCTION
New viral infections in humans
may be emerging at an increasing rate
(1). The safety of the blood supply
is currently maintained by selective
screening of donors (2), pathogen
reduction (3), and nucleic acid and
antibody testing for known viruses,
including human immunodeficiency
virus (HIV), hepatitis B virus (HBV),
hepatitis C virus (HCV), human T cell
lymphotrophic virus (HTLV), and West
Nile virus (WNV). These practices
have made the blood supply extremely
safe from the transmission of known
viruses (the risk of contracting HIV
or HCV through a blood transfusion is
less than 1 in 2,000,000) (4 ).
The largest potential threats to
the blood supply are posed by novel
pathogens, which would escape
current screening techniques. In
order to identify emerging viruses,
an active surveillance system capable
of continually monitoring the blood

supply is needed. Hybridization to
DNA microarrays containing all known
viral sequences and low-stringency
PCR using degenerate primers to
highly conserved viral sequences have
successfully been used to identify and
characterize novel viruses (5,6). These
methods rely on conserved sequences
being present within viral genomes,
which makes them inadequate for the
discovery of completely novel viral
types in human blood samples.
The use of representative differential
amplification (RDA) (7) has led to the
discovery of several novel viruses in
humans, including HCV (8), hepatitis
GB virus (9), herpesvirus 8 (10), and
Torque teno virus (TTV) (11). RDA
was originally intended for comparing
two cellular genomes, and applying
this method to viral discovery in human
blood requires that the composition
of the background host DNA to be
subtracted out is similar in both the
tester and driver samples. In addition,
RDA typically involves large quantities

of DNA, which would require a high
level of viremia before the virus could
be recovered. While RDA is appropriate
if samples from the same individual
are being compared before and after
viral infection, it is not clear that this
approach will be applicable to blood
pooled from multiple individuals.
Two recent studies have presented
viral discovery methods that utilize
selection for viral particles (based on
size, density, and nuclease resistance),
followed by sequence-independent
amplification (12,13). These approaches
have been used to identify new bovine
parvoviruses present in commercial
bovine serum (12), sequence novel
viruses from the plasma of patients
with symptoms of acute viral infection
(14), and diagnose herpes simplex virus
type 1 (HSV-1) in the supernatant of
infected cells isolated from the mouthwashing material of a chronic fatigue
syndrome patient (13).
Several viruses, such as TTV (15–
17), TTV-like mini virus (TLMV) (18),

San Diego State University, San Diego, CA, USA
Vol. 39, No. 5 (2005)

BioTechniques 729

RESEARCH REPORT
Protocol 1. Overview of the Methodology for Obtaining Purified Viral DNA from
Whole Blood Samples
1.
Removal of blood cells by centrifugation
2.

Purification of viral particles by CsCl density-dependent centrifugation
(results may be visualized by electron microscopy; see Figure 1)

3.

Chloroform treatment

4.

DNase I incubation

5.

Concentration and desalting

6.

DNA extraction

7.

PCR for quality control (see Figure 2)

8.

Sequence-independent amplification

9.

DNA shearing

10.

Linker-addition and PCR amplification of fragments

11.

Cloning and sequencing

12.

Bioinformatic analyses

13.

Confirmation by specific PCR (see Figure 3)

SEN virus (SENV) (19), Epstein-Barr
virus (20), and B19 (21) are found in the
blood of healthy people. The process
of discovering novel blood viruses is
hindered by methodological limitations such as low viral DNA content,
abundance of host and mitochondrial
DNA, and the absence of genes that are
conserved among all viruses. Here we
present a method to shotgun-sequence
novel, uncultured DNA viruses directly
from human blood. This method
employs selection based on the physical
properties of viruses combined with
sequence-independent amplification
and cloning. Using this method, we
discovered novel anellovirus sequences
in the blood of healthy donors.
MATERIALS AND METHODS
Blood Collection
All blood collection was performed
by technicians at the General Clinical
Research Center at the Scripps
Research Institute (San Diego, CA,
USA). Ten milliliters of blood were
collected from healthy blood donors
into sodium heparin vacutainers (BD
Biosciences, Franklin Lakes, NJ, USA)
and stored at 4°C until processing
(within 1 week).
Sample Descriptions
Library 1 was constructed from
blood pooled from 20 healthy donors
730 BioTechniques

collected in November 2004. Libraries
2 and 3 were constructed from blood
pooled from 15 healthy donors
collected in February 2005. The pooled
plasma samples for Libraries 1 and 2
were spiked with 107 bacteriophage
M13 particles per milliliter as a tracer to
ensure the recovery of single-stranded
DNA (ssDNA) viruses. Library 3
was not spiked with any tracers. For
screening with specific primers, plasma
was pooled from approximately 100
additional healthy donors (collected
between September 2004 and February
2005).
Isolation of Viral DNA
The methods for obtaining viral
DNA from blood samples are outlined
in Protocol 1. Whole blood samples
were centrifuged at 3000× g at 4°C for
10 min to pellet the blood cells. Eight
and a half milliliters of cell-free plasma
were loaded onto a cesium chloride
(CsCl) step gradient consisting of 1
mL each of 1.7, 1.5, and 1.2 g/mL in
1× phosphate-buffered saline (1× PBS;
137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, 1.4 mM KH2PO4, pH 7.3).
The gradient was designed to capture
all known groups of DNA viruses (22).
The gradients were ultracentrifuged
at 55,000× g at 4°C for 2 h, and the
1.2–1.5 g/mL fraction was collected.
This fraction was stained with SYBR®
Gold (Molecular Probes, Eugene,
OR, USA) and viewed under epifluorescence and electron microscopy

to ensure that it contained virus-like
particles (23,24). The CsCl-purified
viral particles were then incubated with
0.2 volumes of chloroform for 10 min
at room temperature. The chloroform
was pelleted, and the supernatant was
removed and incubated with 2.5 U
DNase I (Sigma-Aldrich, St. Louis,
MO, USA) per microliter of sample
for 2 h at 37°C. This sample was then
concentrated and washed twice with
1× PBS on a Microcon® 30 (Millipore,
Billerica, MA, USA). EDTA was added
to a final concentration of 20 mM to
inactivate the DNase I, and DNA was
then extracted using the QIAamp®
MinElute™ Virus Spin Kit (Qiagen,
Valencia, CA, USA) according to the
manufacturer’s instructions. Total DNA
was also extracted from unprocessed
cell-free plasma from the healthy
donors using the QIAamp Blood Mini
Kit (Qiagen). This was used for the
comparison of human, mitochondrial,
and TTV DNA found in unprocessed
plasma versus viral DNA purified using
the method outlined in Protocol 1.
PCR to Check DNA Quality
Viral DNA extracted from the blood
samples was screened by PCR for the
presence of (i) human 18S rDNA, (ii)
human mitochondrial DNA, and (iii)
TTV. All primer sequences are listed in
Table 1. PCR products positive for TTV
in the nested reaction were sequenced
for verification. The PCR mixture (50
μL total volume) for the specific primer

Figure 1. Transmission electron micrographs
of some viruses found in the blood of healthy
donors.
Vol. 39, No. 5 (2005)

sets contained 5 μL of target DNA, 1×
FideliTaq™ PCR Master Mix (USB,
Cleveland, OH, USA), and 1 μM each
primer. The thermal cycler conditions
were 5 min at 94°C; 35 cycles of 1 min
at 94°C, 1 min at 55°C, and 1 min at
72°C; and 10 min at 72°C.
Electron Microscopy
The CsCl-purified viral particles
were adsorbed to glow-discharged
formvar-coated 200-mesh copper grids
for 5 min. The grids were then stained
in 1% uranyl acetate for 20 s and
viewed using the FEI Tecnai 12 (FEI,
Hillsboro, OR, USA). Digital images
were recorded on a Tietz TemCamF214 camera (TVIPS, Gauting,
Germany).
Recovery of Tracer Viruses
Adenovirus 7. To evaluate the
recovery of known viruses using the
methodology presented here, plasma
samples from healthy human donors
were spiked with 107 adenovirus 7
particles per milliliter. The number of
added viral particles was determined
by direct epifluorescence counts of
viruses (data not shown). The spiked

samples were processed as outlined in
Protocol 1. The presence of adenovirus
7 was determined in both spiked and
unspiked samples based on PCR for the
hexon gene as previously described by
Echavarria et al. (25). The PCR conditions for the detection of the adenovirus
7 sequence were identical to those
described above. Adenovirus 7 was not
used as a tracer in any of the samples
used for constructing the shotgun
libraries.
Bacteriophage M13. In order to
determine the ability of this method
to recover ssDNA viruses, the pooled
plasma used to construct Libraries 1
and 2 were spiked with 107 particles
of bacteriophage M13 (22) per milliliter before processing the samples as
outlined in Protocol 1. The presence
of spiked M13 in the purified viral
samples was not monitored by PCR, but
was determined based on TBLASTX
similarities of the shotgun library
sequences.
Construction of Viral Shotgun
Libraries

Linker-amplified
shotgun
libraries—Libraries 1 and 2. Once
viral DNA samples were determined
to be free of mitochondrial and host
DNA, linker-amplified shotgun
libraries (LASLs) were constructed
by Lucigen (Middleton, WI, USA)
using a modification of the protocol
described by Breitbart et al. (www.
sci.sdsu.edu/PHAGE/LASL) (26).
Total DNA was initially amplified
using the strand-displacement
enzyme Bst DNA polymerase
(New England BioLabs, Beverly,
MA, USA). The amplified DNA
Figure 2. Control PCR assays to determine the qual- was then sheared into 1–2 kb
ity of the purified viral DNA. A DNA sample was fragments using a HydroShear®
considered a good candidate for library construction if (GenMachines, San Carlos, CA,
it was negative in the PCR for human 18S rDNA and
USA), the fragments were endmitochondria, and positive in the PCR for TTV. Purified
viral DNA, viral DNA isolated from healthy donor plas- repaired, and short double-stranded
ma using the method presented in Protocol 1; plasma, DNA (dsDNA) linkers were ligated
total DNA isolated from healthy donor plasma before to the ends. These fragments were
any processing; +, DNA extracted from whole blood then PCR-amplified using primers
(18S and mitochondria reactions), DNA from a healthy
donor plasma sample known to be positive for TTV, and to the linkers and cloned into the
DNA isolated from the glycerol stock of adenovirus 7, pSMART vector as previously
respectively; -, no target DNA added to PCR; spiked described (26). Transformants were
sample, purified viral DNA isolated from a plasma sequenced by SymBio (Menlo Park,
sample spiked with 107 adenovirus 7 particles per milliCA, USA) using the AmpL2 primer.
liter; unspiked sample, purified viral DNA isolated from
the same plasma sample processed in parallel, but not Sequences have been submitted to
spiked. TTV, Torque teno virus.
Vol. 39, No. 5 (2005)

GenBank® with the accession nos.
DQ092578–DQ092599.
GenomiPhi and whole genome
amplification—Library 3. For
Library 3, an alternative method for
constructing shotgun libraries was
tested on the same sample that was
used to make Library 2. The DNA
was first amplified using the stranddisplacement φ29 DNA polymerase
(GenomiPhi™; Amersham Biosciences,
Piscataway, NJ, USA) according to the
manufacturer’s protocol. The products
of the GenomiPhi reaction were then
fragmented and further amplified using
the GenomePlex® Whole Genome
Amplification Kit (Sigma-Aldrich).
The resulting OmniPlex library was put
through a PCR clean-up kit (Mo Bio
Laboratories, Solana Beach, CA, USA)
and cloned using pGEM® (Promega,
Madison, WI, USA). Transformants
were sequenced by the San Diego
State University Microchemical Core
Facility (San Diego, CA, USA) using
the M13F primer.
Bioinformatic Analysis of Shotgun
Library Sequences
Quality scores were assigned to the
sequences using Phred (27,28), and
the sequences were trimmed using
Sequencher™ 4.0 (Gene Codes, Ann
Arbor, MI, USA). Sequences were
trimmed until there were not more
than 3 bases with confidence scores
below 25 within 25 bases of either
end. Sequences were compared against
GenBank using TBLASTX (29,30).
For phylogenetic analyses of the novel
anellovirus sequences (SDSU1 and
SDSU2), sequences showing significant TBLASTX hits were downloaded
from GenBank. The sequences were
then aligned using CLUSTALX (31)
and neighbor-joining trees were
constructed, bootstrapped 1000 times,
and analyzed using Treeview (see
Figure 3) (32).
PCR for Specific Sequences
Identified by Shotgun Library
Sequencing
Primer 3 (33) was used to design
primers to amplify three of the
viral sequences identified through
sequencing of the shotgun libraries.
BioTechniques 731
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The primers were designed to amplify
sequences that had top TBLASTX
hits to an uncultured anellovirus
(DQ092578), SENV (DQ092579), and
TLMV (DQ092580).
The PCR mixture (50 μL total
volume) for the specific primer sets
contained 5 μL of target DNA, 1×
FideliTaq PCR Master Mix, and 1 μM
each primer. The thermal cycler conditions were 5 min at 94°C; 35 cycles
of 1 min at 94°C, 1 min at 60°–0.5°C
per cycle, 1 min at 72°C; and 10 min
at 72°C. The identity of PCR positives
was confirmed by sequencing.

losses of viral DNA (Figure 2 and data
not shown).
Recovery of Viral DNA
PCR-based control experiments
showed that both naturally present
TTV and artificially spiked adenovirus
7 tracers were recovered from human
plasma using this method (Figure 2).
Because concentrations of adenovirus
can reach up to 1010 viruses per milliliter in the blood of infected patients
(34), an addition of 107 viruses per
milliliter is physiologically relevant.

TBLASTX analysis of the sequences
from the viral shotgun libraries showed
that this method recovered artificially
spiked bacteriophage M13 as well
as naturally present anelloviruses.
For the libraries that were artificially
spiked with 107 bacteriophage M13
particles per milliliter, 20%–40% of
the shotgun library sequences originated from bacteriophage M13 (as
determined by TBLASTX similarity).
These sequences could be assembled
into larger contigs, demonstrating
that the genome of a virus present
at a concentration of 107 virions

RESULTS
Electron Microscopy of Purified
Blood Viruses
Electron microscopy (Figure 1)
verified the presence of viral particles
in the plasma of healthy blood donors.
The majority of the viral particles
observed were approximately 100
nm in diameter. In all cases, the viral
particles were concentrated in the band
isolated from the CsCl gradient, and
no viruses were observed in the other
fractions after centrifugation (data not
shown).
Removal of Human and
Mitochondrial DNA
Because high host and mitochondrial DNA concentrations overwhelmed
the viral DNA signal (data not shown),
CsCl density-dependent centrifugation,
chloroform, and DNase I treatments
were used to remove human and
mitochondrial DNA. Free human DNA
was removed beyond the detection limit
of the PCR assay by the CsCl centrifugation and DNase I treatment (Figure
2). The addition of chloroform was
necessary to disrupt the mitochondrial
membranes, making them susceptible
to DNase I digestion. Viral nucleic
acids were protected from DNase I
degradation by the viral protein capsids,
although some enveloped viruses may
have been lost. PCR assays showed that
this method significantly reduced the
concentrations of host and mitochondrial DNA compared with whole
plasma, without resulting in observable
732 BioTechniques

Figure 3. Novel anellovirus sequences identified in the plasma of healthy donors. Sequences having
top TBLASTX hits to small anellovirus 2 (DQ092578), SEN virus (DQ092579), and TLMV (DQ092580)
were recovered from the shotgun libraries. (A) Specific PCR primers designed to amplify these novel
anellovirus sequences verified the presence of these sequences in the plasma of different healthy donors. (B–D) Phylogenetic trees showing the relationships of the anellovirus sequences identified in this
study (SDSU1 and SDSU2) to previously sequenced anelloviruses. Sequences identified in this study are
shown in red, SENV sequences are green, TTV sequences are blue, and the small anellovirus 2 sequence
is light purple. All positive PCR products were sequenced for verification. The scale bar represents 0.1
changes per 100 bp. TTV, Torque teno virus; TLMV, TTV-like mini virus; SENV, SEN virus.
Vol. 39, No. 5 (2005)

viruses in this protocol
through the removal of
blood cells by centrifugation, the purification of
18SF
Human 18S
Maxim Biotech
5′-CCGCAGCTAGGAATAATGGAATAGGAC-3′
viruses by CsCl density18SR
rDNA
(San Francisco,
5′-GTTAGCATGCCAGAGTCTCGTTCGT-3′
CA, USA)
dependent centrifugation,
chloroform addition to
Mit3130F
5′-AGGACAAGAGAAATAAGGCC-3′
Human
lyse mitochondria, and
Mit3301R
5′-TAAGAAGAGGAATTGAACCTCTGACTGTAA-3′
mitochondria
(35)
DNase I treatment to
TTVBF1
5′-GTGGGACTTTCACTTGTCGGTGTC-3′
remove nonviral DNA.
TTVBR1
5′-GACAAATGGCAAGAAGATAAAGGCC-3′
TTVCF1
5′-CAGACTCCGAGTTGCCATTGGAC-3′
TTV
This selection elimiTTVCR1
5′-CACGTGTCGGGGCCTACTTCCG-3′
(outer PCR)
(41)
nates the need for the
background
human
TTVBF2
5′-AGGTCACTAAGCACTCCGAGCG-3′
TTVBR2
5′-GCGAAGTCTGGCCCCACTCAC-3′
DNA signal subtraction
TTVCF2
5′-GCAACGAAAGTGAGTGGGGCCAG-3′
TTV
that is performed in
TTVCR2
5′-GGTTTCCGCCGAGGATGACCT-3′
(inner PCR)
(41)
RDA analysis (8). It is
hexAA1885F
5′-GCCGCAGTGGTCTTACATGCACATC-3′
Adenoviimportant to note that
hexAA1913R
5′-CAGCACGCCGCGGATGTCAAAGT-3′
rus 7
(25)
the method outlined here
employs a CsCl gradient
AnelloF
5′-GCACATTCTTTTAAGAGCTGTTTTT-3′
Novel anelAnelloR
5′-AGCAGACCCAGGACAACAAG-3′
lovirus
This study
for purifying viruses
instead of filtration-based
SENF
5′-AAGGCAAAGGAAACATGGTG-3′
techniques. Filtering
SENR
5′-TGTGAAGGGGCCTAGTGTTC-3′
Novel SENV
This study
samples through a 0.2-μm
TLMVF
5′-CGAACCATATCCAACAGAACAA-3′
filter (12,13) to remove
TLMVR
5′-GTGGTAATGATGGCATGCTG-3′
Novel TLMV
This study
cells and mitochondria
TTV, Torque teno virus; SENV, SEN virus; TLMV, TTV-like mini virus.
may result in the loss of
large viral particles (e.g.,
per milliliter would be recovered at
A 284-bp sequence recovered from
some herpesviruses are 0.2 μm in
high coverage, and it is possible that
Library 3 (SDSU2; DQ092579) was
diameter) (22).
complete genomes could be assembled
67% identical on the nucleotide level
using this method. Several naturally
and 63% identical on the amino acid
Depletion of Human and
occurring sequences with similarity to
level to SENV (AY206683) (Figure 3,
Mitochondrial DNA
known viruses were observed in each
C and D). These divergent anellovirus
library (Table 2). In addition, approxisequences constitute novel viruses
Removal of free human host DNA
mately 10% of the shotgun sequences
identified using the methods presented
was a critical step in this method
had no similarities in GenBank with
here and contribute to the wide genomic
because free human DNA may be
an E-value <0.001. These sequences
heterogeneity of this group.
present at significantly higher concenmay represent undescribed groups of
trations than viral DNA in plasma. Free
viruses.
Specific PCR to Confirm the
human DNA was removed beyond the
Presence of Novel Anelloviruses
detection limit of our PCR conditions
Identification of Novel Viral
for human 18S rDNA by the CsCl
PCR primers designed to amplify
Sequences
density-dependent centrifugation and
three of the novel anellovirus sequences
DNase I treatment (Figure 2).
Sequences from the healthy donor
identified in this study confirmed
In addition to removing free DNA,
plasma shotgun libraries with signiftheir presence in blood pooled from
it was also necessary to remove
icant TBLASTX similarities to known
100 different healthy donors (Figure
mitochondria from the plasma sample.
viruses are listed in Table 2. Because
3A). PCR positives were sequenced
Chiu et al. (35) have shown that
numerous recent studies have demonfor confirmation, and all amplified
mitochondrial DNA is present in human
strated the presence of anelloviruses in
sequences were identical to those
plasma in both particle-associated and
the blood of the general population, we
initially recovered from the shotgun
free forms. Preliminary experiments
further analyzed two of these sequences.
libraries.
showed that if the mitochondria were
Figure 3 shows the phylogenetic
not specifically removed from the
relationships of these novel sequences
plasma sample (by chloroform and then
to previously sequenced anelloviruses.
DISCUSSION
DNase I treatment), all the sequences
A 286-bp fragment recovered from
recovered from the shotgun libraries
Library 2 (SDSU1; DQ092578) was
The method described here provides
were mitochondrial in origin (data
41% identical on the nucleotide level
a new technique for sequencing novel
not shown). The depletion protocols
and 35% on the amino acid level to
DNA viruses from plasma samples.
described here efficiently reduced the
small anellovirus 2 (AY787831).
There is a high level of selection for
concentrations of mitochondrial DNA
Table 1. Primer Sequences Utilized in this Study
Primer Name
Sequence

Vol. 39, No. 5 (2005)

Target

Reference
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Table 2. Sequences from the Healthy Blood Donor Shotgun Libraries with
Significant TBLASTX Similarities to Known Viruses
Library
Top Known Virus Hit
TBLASTX E-value
(No.)
1
1
2

TTV-like mini virus
TTV-like mini virus
TTV-like mini virus

9e-04
3e-25
2e-15

1
1
1
1

Heliothis zea virus 1
Heliothis zea virus 1
Heliothis zea virus 1
Heliothis zea virus 1

1e-15
2e-16
9e-17
4e-11

1

Pseudorabies virus

7e-05

1

Bacteriophage φ3626

2e-27

1
1

Cowpox virus
Cowpox virus

1e-19
1e-19

1
1

Human endogenous retrovirus H (HERV-H)
Human endogenous retrovirus H (HERV-H)

1e-25
5e-25

1

Bacteriophage EJ-1

2e-05

1

Human herpesvirus 3

5e-05

1
1

TTV
TTV

2e-24
1e-04

2

Small anellovirus 2a

3e-06

1

Methanobacterium phage psiM2

1e-04

1

Spodoptera litura nucleopolyhedrovirus

7e-08

1

Chlamydia phage φCPAR39

1e-09

3

SEN virusa

8e-38

TTV, Torque teno virus.
aSequences that were further analyzed to identify phylogenetic relationships to known viruses
(Figure 3, B–D).

to the point that we could no longer
detect mitochondrial DNA by PCR
(Figure 2), and only a few sequences
with TBLASTX similarities to
mitochondria were recovered from the
shotgun libraries.
Identification of Novel Anellovirus
Sequences
Among the shotgun sequences
obtained from healthy donor plasma,
several sequences with similarities to
the anellovirus family were identified
(Table 2). The anellovirus family
(formerly part of the circovirus family)
is a highly heterogeneous group of
single-stranded, circular viruses,
including TTV, TLMV, and SENV.
Using the methodology presented
here, we have detected several novel
anellovirus sequences, which suggests
that there is still undiscovered
diversity within this family of viruses.
Anelloviruses are present worldwide
and are found in over 70% of the
general population of Asia, Africa,
734 BioTechniques

and South America (17). These viruses
appear to be less prevalent in the
U.S. and Europe (16); however, TTV
viremia occurs in 8%–42% of healthy
blood donors in the U.S. (36,37) and
47%–73% of individuals in European
countries (17). It has been suggested
that TTV and SENV are associated with
posttransfusion hepatitis; however, no
definitive links between the presence
of these viruses and clinical pathology
have been demonstrated.
Possible Loss of Enveloped Viruses
The chloroform treatment that is
required for lysing mitochondria will
also disrupt the membrane of enveloped
viruses. In control experiments with the
enveloped virus HSV-1, the protein
capsid remained intact and protected
the viral DNA from degradation even
after removal of the envelope (data
not shown). Therefore, at least some
enveloped viruses can be recovered
using this method. However, the capsid
of some viruses may not be stable after

the removal of the envelope, and if these
viruses were rendered DNase-sensitive,
then they would not be recovered using
this approach. One possible alternative
to the chloroform treatment is antibodybased depletion of the mitochondria.
However, we found that this method
did not consistently reduce mitochondrial numbers and had variable effects
on the efficiency of viral recovery (data
not shown).
Blood Sample Collection and
Storage
This method was tested on blood
samples that were collected using
heparin as the anticoagulant and stored
at either room temperature or 4°C.
One needs to take caution when using
blood preserved in EDTA, acid citrate
dextrose, sodium citrate, and potassium
or ammonium oxalate because these
compounds chelate cations that are
required for effective DNase I digestion
and may compromise the integrity of
viral particles. Further studies need to
be performed to determine the ability
of this method to recover viruses
from frozen samples, serum, or blood
fraction paste.
Applications of this Protocol
Here we have shown that a method
based on the selection for viral particles
followed by sequence-independent
amplification can recover DNA viral
sequences from the blood of healthy
people. Applying this technique to large
donor pools will allow for the identification of viruses normally present
in the blood supply. This will provide
a baseline against which samples
can be compared in order to identify
emerging threats even before clinical
symptoms are observed. In addition to
its use for monitoring the blood supply,
this method can also be applied to
diagnose unknown viral infections in
patients. For example, more than 50%
of pneumonia cases and almost 60%
of encephalitis cases requiring hospitalization in the U.S. have no known
etiology (38,39). In the case of many
viral infections, viremia phases are
characterized by high viral titers, which
would facilitate the sequencing of the
viruses using this method. Knowledge
Vol. 39, No. 5 (2005)

about the identity of these viruses may
yield insights into treatment options.
Because many viruses are cellassociated (e.g., Epstein-Barr virus
and cytomegalovirus), one logical
step for further development of this
method is its application to human
tissues. The method outlined here
can also easily be adapted to identify
RNA viruses through the addition of
a reverse transcription step before the
sequence-independent amplification
(12,13). Finally, this method can also
be applied to detect novel DNA viruses
within animal populations, which is of
potential importance for both farming
and human health.
The protocol described here can
be completed (sample collection
to sequence data) in fewer than 2
days, which is faster than traditional
protocols that require obtaining the
virus in culture. Once sequence data
are obtained from the newly identified
virus of interest, PCR primers can
be designed to rapidly screen a
large number of samples in order to
determine the prevalence, abundance,
and geographical distribution of the
novel virus. The safety of the blood
supply can be monitored, and viral
sequences can be compared in order to
determine the origin of the virus and
epidemiological links between patients
(40).
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